Renivace and interstitial lung disease Patient Reports February 13, 2012

Renivace Side Effects Report #5817334-6
Renivace side effect was reported by a Physician from JAPAN on June 30, 2008. Male patient, 85 years of age, was diagnosed with hypertension and was treated with Renivace. After drug was administered, patient experienced the following side effects: interstitial lung disease. Renivace dosage: unknown. During the same period patient was treated with ENALAPRIL MALEATE, LASIX, HARNAL, VESICARE. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #5914511-0
Renivace side effect was reported by a Physician from JAPAN on Sept 22, 2008. Male patient, 85 years of age, was diagnosed with hypertension and was treated with Renivace. After drug was administered, patient experienced the following side effects: blood pressure decreased, eosinophilic pneumonia, interstitial lung disease, pneumonia primary atypical, respiratory disorder. Renivace dosage: unknown. During the same period patient was treated with ENALAPRIL MALEATE, LASIX, HARNAL, VESICARE, MICARDIS, DOXAZOSIN MESYLATE. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #5200966-6
Renivace side effect was reported by a Physician from JAPAN on Dec 15, 2006. Male patient, 77 years of age, weighting 141.1 lb, was diagnosed with hypertension, thrombosis prophylaxis, diabetes mellitus non-insulin-dependent, gastric ulcer and was treated with Renivace. After drug was administered, patient experienced the following side effects: acute myocardial infarction, alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood immunoglobulin e increased, blood lactate dehydrogenase increased, c-reactive protein increased, interstitial lung disease, lymphocyte stimulation test positive. Renivace dosage: 5 MG QD PO. During the same period patient was treated with BUFFERIN, EUGLUCON, OMEPRAL, PANALDINE, DIOVAN. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #5176426-8
Renivace side effect was reported by a Physician from JAPAN on Nov 21, 2006. Male patient, 77 years of age, was diagnosed with hypertension, prophylaxis, thrombosis prophylaxis and was treated with Renivace. After drug was administered, patient experienced the following side effects: interstitial lung disease. Renivace dosage: 2.5 MG Q DAY PO. During the same period patient was treated with DIOVAN, EUGLUCON, OMEPRAL, PANALDINE. Patient was hospitalized. Patient recovered.


Renivace Side Effects Report #5441607-2
Renivace side effect was reported by a Physician from JAPAN on Aug 16, 2007. Female patient, 76 years of age, was diagnosed with hypertension and was treated with Renivace. After drug was administered, patient experienced the following side effects: interstitial lung disease, lymphocyte stimulation test positive. Renivace dosage: (2.5 MG QD ORAL). During the same period patient was treated with NORVASC, PRAVASTATIN, OMEPRAZOLE. Patient recovered.

Renivace Side Effects Report #4650538-7
Renivace side effect was reported by a Pharmacist from on Apr 14, 2005. Female patient was diagnosed with hypertension and was treated with Renivace. After drug was administered, patient experienced the following side effects: interstitial lung disease. Renivace dosage: unknown. During the same period patient was treated with ADALAT, ASPIRIN, CIBENOL, ZANTAC. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #4591098-9
Renivace side effect was reported by a Physician from on Feb 02, 2005. Male patient, 76 years of age, was treated with Renivace. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine decreased, blood lactate dehydrogenase increased, condition aggravated, haematocrit decreased, haemoglobin decreased, interstitial lung disease, pneumonia aspiration. Renivace dosage: 1.25 MG Q DAY PO. During the same period patient was treated with VANCOMYCIN HYDROCHLORIDE, GASTER, VITAMIN ADDITIVE, BISOLVON. Patient died on 10/08/2004.

Renivace Side Effects Report #5390817-1
Renivace side effect was reported by a Physician from JAPAN on June 28, 2007. Male patient, 70 years of age, weighting 154.3 lb, was treated with Renivace. After drug was administered, patient experienced the following side effects: interstitial lung disease. Renivace dosage: 5 MG QD ORAL. During the same period patient was treated with TAKEPRON, ARTIST, LASIX, GRAMALIL, ASPIRIN, TICLOPIDINE, DEPAS, AMLODIPINE. Patient was hospitalized. Patient recovered.

Renivace Side Effects Report #5500154-X
Renivace side effect was reported by a Physician from JAPAN on Oct 12, 2007. Male patient, 70 years of age, weighting 154.3 lb, was treated with Renivace. After drug was administered, patient experienced the following side effects: c-reactive protein increased, interstitial lung disease, white blood cell count increased. Renivace dosage: (5 MG QD ORAL). During the same period patient was treated with TAKEPRON, CARVEDILOL, LASIX, GRAMALIL, ASPIRIN, TICLOPIDINE, DEPAS, AMLODIPINE. Patient was hospitalized. Patient recovered.